Lucy Lambriex/DigitalVision via Getty Images Investment Overview I last covered Organon (NYSE:OGN), a company whose stock I own, back in mid-February, reviewing a positive set of full-year 2023 earnings that sent shares rising in value from ~$16, to ~$19, adding fresh momentum to a bull run that began in December 2023. Until late-December, Organon stock had experienced a torrid 2023, sinking in value from $32 per share in January, to ~$11.5 at the end of November, for an overall loss of nearly 65%. The  ...